EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Reference library Primary sources checked October 28, 2026 Computed charts

Cosmetic formulation and stability

A botanical cosmetic has to hold together, resist microbes at its own pH and keep its quality to the end of its labeled life. This page gives the emulsifier arithmetic, preservative chemistry, challenge-test criteria and stability conditions behind those three requirements.

1.0%Maximum phenoxyethanol in a ready-for-use cosmetic in the EU (Regulation 1223/2009, Annex V, entry 29)
15%Share of sorbic acid (pKa 4.76) left undissociated, the active form, at pH 5.5 (Henderson–Hasselbalch)
3 logsBacterial kill by day 7 for ISO 11930 criterion A; USP <51> asks for 2 logs by day 14 in topical products
40 °C / 75% RHICH Q1A(R2) accelerated condition, six months at submission for a new drug product

Status. EUTECNIQ is in formation and has no laboratory, products, customers or test results. This page is reference material; nothing on it describes work EUTECNIQ has done. Regulatory text is summarized, not legal advice.

Ingredients

How botanicals enter a formula

A plant reaches a cosmetic as an extract, a fatty oil or butter, an essential oil or a distilled water (hydrosol), and the form decides which phase it joins. EU ingredient lists use the Commission's glossary of common ingredient names, which takes the INCI names published by the Personal Care Products Council; botanical entries read Latin genus and species, plant part, then form.

Botanical forms, the phase they join and glossary names that show the naming pattern
FormWhat it isJoinsGlossary name (entry no.)
ExtractConstituents taken into a solvent, then concentrated or carried in a diluentWater or oil phase, by solvent and polarityCAMELLIA SINENSIS LEAF EXTRACT (1136); ACHILLEA MILLEFOLIUM FLOWER EXTRACT (1052)
Fatty oil, butterTriglyceride-rich lipids pressed or extracted from seeds and fruits; butters are solid at room temperatureOil phaseNamed by the same pattern; check each name in the glossary
Oil (volatile or other)Distilled or expressed oilsOil phase; fragrance allergens may need labelingABIES ALBA CONE OIL (683)
Distilled water (hydrosol)Aqueous distillateWater phaseACHILLEA MILLEFOLIUM FLOWER WATER (1053); ACORUS CALAMUS RHIZOME WATER (1123)

Commission Decision (EU) 2022/677 of 31 March 2022, glossary of common ingredient names (recitals 1 and 3; Annex entries as numbered); applies from April 29, 2023, replacing Decision (EU) 2019/701. Regulation (EC) No 1223/2009, Article 19(1)(g): ingredient list in descending order of weight.

Structure

Six formulation types

The continuous phase sets how a product feels, what dilutes it and where microbes can grow. An oil-in-water emulsion is aqueous outside, so it dilutes with water and conducts electricity; a water-in-oil emulsion is oily outside. ISO 11930 exempts products classed as low microbiological risk under its Annex A and ISO 29621; that classification is a documented assessment.

Cosmetic formulation types by continuous phase and the botanical forms each carries
TypeContinuous phaseBotanical forms it carriesTypical first failure
O/W emulsion (lotion, cream)WaterExtracts and hydrosols outside; oils and butters in the dropletsCreaming, coalescence, microbial growth in the water
W/O emulsionOilOils outside; aqueous extracts in the dropletsSedimentation and coalescence of water droplets
Aqueous gelWater thickened by a polymerWater-soluble extracts; oils need a solubilizerViscosity loss with salts, pH drift or extract load
Serum (aqueous or hydroalcoholic)Water, often with glycols or ethanolWater-soluble extracts; oils as micelle-solubilized dropsHaze or precipitation; color and odor change
Anhydrous balm, oilOils, butters, waxesOils, butters, oil-soluble extractsOxidative rancidity; wax or fat recrystallization
Surfactant system (cleanser, shampoo)Water with micellesExtracts; oils solubilized in micellesViscosity and clarity change; preservative loss to micelles

Dilution and conductivity of aqueous systems: Griffin, J Soc Cosmet Chem 1954;5:249–256. Low-risk products: ISO 11930:2019 scope (ISO catalog page). Failure modes are general formulation science; see Emulsions and colloids for the physics and Cosmetics and personal care for the market view of each format.

In an oil-in-water emulsion the emulsifier's heads face an outer water phase; in water-in-oil they face into the water dropletsSchematic, not to scale
Two circular fields of view side by side. Left: an oil-in-water emulsion, oil droplets of mixed sizes dispersed in continuous water, each coated by emulsifier with its water-loving heads facing the water. Right: a water-in-oil emulsion, water droplets dispersed in continuous oil, with the emulsifier heads facing into the water droplets. Magnified insets show the orientation of the emulsifier at the interface. Notes give Griffin's HLB ranges: about 8 to 18 for oil-in-water emulsifiers and 4 to 6 for water-in-oil emulsifiers. Schematic, not to scale.
HLB ranges: Griffin WC. J Soc Cosmet Chem 1949;1:311–326, Table 2. Dilution and conductivity: Griffin WC. J Soc Cosmet Chem 1954;5:249–256. Droplet populations are seeded random drawings. Illustration by EUTECNIQ. Full-size SVG
Emulsifier choice

The HLB system

Griffin's hydrophile–lipophile balance rates a nonionic emulsifier by the weight share of its water-loving part: HLB = E/5 for an ethoxylate with E% oxyethylene, which equals 20 × Mh/M. For polyol fatty esters he gave HLB = 20(1 − S/A), S the saponification number of the ester and A the acid number of the acid. Blends average by weight, and each oil phase has a required HLB at which emulsification works best.

HLB of named emulsifiers (Griffin 1954, Table 1; values believed correct to ±1)
Chemical designation (trade name in the table)HLB
Sorbitan trioleate (Span 85)1.8
Glycerol monostearate (Atmul 67)3.8
Sorbitan monooleate (Span 80)4.3
Sorbitan monostearate (Span 60)4.7
Sorbitan monopalmitate (Span 40)6.7
Sorbitan monolaurate (Span 20)8.6
Polyoxyethylene sorbitan monostearate (Tween 60)14.9
Polyoxyethylene sorbitan monooleate (Tween 80)15
Polyoxyethylene sorbitan monolaurate (Tween 20)16.7
Sodium oleate (anionic)18
Required HLB of oil-phase materials (Griffin 1954, Table 2)
MaterialFor W/OFor O/W
Cottonseed oil–7.5
Paraffin (household)49
Microcrystalline wax–9.5
Mineral oil, heavy410.5
Petrolatum410.5
Beeswax510–16
Cetyl alcohol–13
Lanolin, anhydrous815
Stearic acid–17
Worked example: an oil phase of 80% cottonseed oil and 20% cetyl alcohol needs HLB 8.6, met by 38% Tween 60 in Span 60Computed from Griffin's values
Blend HLB against the weight fraction of the hydrophilic emulsifier for two sorbitan-ester pairs. A required HLB of 8.6 is met at 38% polyoxyethylene sorbitan monostearate with sorbitan monostearate, or 40% polyoxyethylene sorbitan monooleate with sorbitan monooleate.0481216Blend HLB0%25%50%75%100%Hydrophilic emulsifier in the blend, % by weightRequired HLB 8.6 ± 1Span 60 / Tween 60: HLB = 4.7 + (14.9 − 4.7)·xSpan 60 / Tween 60: 38.2% hydrophilic member gives HLB 8.6Span 80 / Tween 80: HLB = 4.3 + (15.0 − 4.3)·xSpan 80 / Tween 80: 40.2% hydrophilic member gives HLB 8.638.2%40.2%Span 60 / Tween 604.7 → 14.9Span 80 / Tween 804.3 → 15.0Blend HLB against the weight fraction of the hydrophilic emulsifier for two sorbitan-ester pairs. A required HLB of 8.6 is met at 38% polyoxyethylene sorbitan monostearate with sorbitan monostearate, or 40% polyoxyethylene sorbitan monooleate with sorbitan monooleate.0481216Blend HLB0%25%50%75%100%Hydrophilic emulsifier in the blend, % by weightRequired HLB 8.6 ± 1Span 60 / Tween 60: HLB = 4.7 + (14.9 − 4.7)·xSpan 60 / Tween 60: 38.2% hydrophilic member gives HLB 8.6Span 80 / Tween 80: HLB = 4.3 + (15.0 − 4.3)·xSpan 80 / Tween 80: 40.2% hydrophilic member gives HLB 8.638.2%40.2%Span 60 / Tween 60 (4.7 → 14.9)Span 80 / Tween 80 (4.3 → 15.0)
Required HLB = 0.8 × 7.5 + 0.2 × 13 = 8.6. Fraction of the hydrophilic member x = (8.6 − 4.7)/(14.9 − 4.7) = 0.382 for Span 60/Tween 60 and (8.6 − 4.3)/(15.0 − 4.3) = 0.402 for Span 80/Tween 80. Values: Griffin, J Soc Cosmet Chem 1954;5:249–256, Tables 1–2; weight-average blending: Griffin, J Soc Cosmet Chem 1949;1:311–326.
Data table and limits of the method
Blend HLB at selected compositions
Hydrophilic member, % by weightSpan 60 / Tween 60Span 80 / Tween 80
0%4.74.3
38.2%8.68.4
40.2%8.88.6
55%10.310.2
100%14.915.0

Griffin's own 1949 example blended Span 60 and Tween 60: 45/55 gave a calculated HLB of 10.3, the ratio he selected from his series for an oil phase of estimated required HLB about 10. He wrote in 1954 that the system "lacks exactness" and that a correct HLB must be paired with the right chemical type; ionic emulsifiers do not follow the weight-percentage rule and must be measured. The required HLB is a starting point for a test series, not a specification.

Griffin's HLB ranges by use (1949, Table 2)
HLB rangeUse
4–6W/O emulsifiers
7–9Wetting agents
8–18O/W emulsifiers
13–15Detergents
15–18Solubilizers

Griffin WC. Classification of surface-active agents by "HLB". J Soc Cosmet Chem 1949;1:311–326 (Table 2; blending rule p. 313; worked example pp. 324–325). Griffin WC. Calculation of HLB values of non-ionic surfactants. J Soc Cosmet Chem 1954;5:249–256 (equations and examples pp. 250–251; Tables 1 and 2).

Physical stability

Why emulsions separate

An emulsion is thermodynamically unstable; formulation only slows its breakdown. Each mechanism has its own driver and its own sign in a stability sample. The physics, with calculators, is on Emulsions and colloids; this table maps each mechanism to what a cosmetic stability program looks for.

Emulsion breakdown mechanisms and what a stability sample shows
MechanismDriverSign in a sampleFormulation lever
Creaming or sedimentationDensity difference; rate rises with droplet radius squared (Stokes)Layer at the top or bottom; redisperses on shakingSmaller droplets; thicker continuous phase
FlocculationWeak attraction between dropletsClusters under the microscope; viscosity changeSteric or charge stabilization
CoalescenceRupture of the film between dropletsGrowing droplets, then free oil or waterEmulsifier type and amount (HLB)
Ostwald ripeningHigher Laplace pressure in small droplets; oil diffuses through the waterMean droplet size rises with timeAdd a less water-soluble oil to the droplets
Phase inversionChange in emulsifier balance with temperature or compositionO/W becomes W/O (or the reverse)Hold composition and process temperature

Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 2004;108–109:303–318 (Ostwald ripening and its control with a less soluble oil). Izquierdo P et al. Langmuir 2004;20:6594–6598 (temperature-driven inversion). Stokes and Laplace relations as derived on Emulsions and colloids.

Process

Scaling up an emulsion

A bigger, geometrically similar mixer cannot hold tip speed and power per volume constant at the same time, and the rule chosen changes the shear the droplets see. Phase temperatures, the order in which phases meet and the cooling rate also belong in the batch record: in the phase inversion temperature method, emulsification starts at the emulsifier's HLB temperature and the batch is then cooled quickly.

A 2 L laboratory batch scaled to 2,000 L under two rules (geometric similarity, turbulent flow, constant power number)
QuantityLaboratoryConstant tip speedConstant power per volume
Linear scale factor k = (V₂/V₁)1/311010
Impeller diameter D0.05 m0.50 m0.50 m
Speed N1,000 rpm100 rpm215 rpm
Tip speed πND2.6 m/s2.6 m/s5.6 m/s
Power per volume, ∝ N³D²10.10×1
Reynolds number, ∝ ND²110×21.5×

Arithmetic from P = Po·ρ·N³·D⁵ (constant Po in turbulent flow), tip speed = πND and Re = ρND²/μ; laboratory speed and diameter are illustrative inputs. The full scale-up model is on Scale-up and tech transfer. PIT method: Izquierdo P, Esquena J, Tadros TF et al. Langmuir 2004;20(16):6594–6598.

Microbial protection

How preservatives work

The preservatives below act mainly on the microbial membrane and the proton gradient across it. Weak organic acids work only in their undissociated form, which crosses the membrane and then releases protons inside the cell, so their activity depends on the pH of the water phase. Chelators, potentiators and low water activity add further hurdles; Leistner's hurdle concept combines several sub-lethal stresses.

Mechanisms of preservative classes, from the primary studies
ClassMechanism reportedSource
Parabens (methyl, butyl)Selectively eliminated the pH gradient (ΔpH) across E. coli membrane vesicles; at higher concentrations inhibited DNA and RNA synthesisEklund, J Gen Microbiol 1985; Nes and Eklund, J Appl Bacteriol 1983
PhenoxyethanolPotassium efflux and disorganization of the outer envelope below lethal levels; leakage and gross membrane damage at lethal levelsGilbert, Beveridge and Crone, Microbios 1977
Benzoic and sorbic acidsBenzoate enters yeast cells undissociated and lowered intracellular pH by more than 1 unit, inhibiting phosphofructokinase so ATP fell; sorbic acid eliminated ΔpH across E. coli membrane vesiclesKrebs et al., Biochem J 1983; Eklund, J Gen Microbiol 1985
Chelators (EDTA)Remove Mg²⁺ and Ca²⁺ from the Gram-negative outer membrane, making it permeableVaara, Microbiol Rev 1992
Multifunctional potentiator (ethylhexylglycerin)0.075% ethylhexylglycerin with 0.675% phenoxyethanol gave >5 log kill of E. coli in 30 min through membrane damage; neither alone was lethal at those levelsLangsrud et al., PLoS One 2016 (co-authors employed by a preservative maker)
At pH 5.5 only 15% of sorbic acid and 4.8% of benzoic acid are in the active, undissociated formComputed from verified pKa
Fraction of sorbic acid (pKa 4.76) and benzoic acid (pKa 4.20) present in the undissociated, antimicrobially active form as a function of pH, from the Henderson–Hasselbalch equation. At pH 5.5 the fractions are 15% and 4.8%; at pH 7 they are below 1%.0%25%50%75%100%Undissociated acid (HA)345678pH of the water phasepH 5 to 6 band, shown for referenceSorbic acid, pKa 4.76Sorbic acid: 50% undissociated at pH = pKa = 4.76Sorbic acid at pH 5.5: 15.4% undissociatedBenzoic acid, pKa 4.204Benzoic acid: 50% undissociated at pH = pKa = 4.204Benzoic acid at pH 5.5: 4.8% undissociated15.4%4.8%pH 5.5Sorbic acidpKa 4.76Benzoic acidpKa 4.20Fraction of sorbic acid (pKa 4.76) and benzoic acid (pKa 4.20) present in the undissociated, antimicrobially active form as a function of pH, from the Henderson–Hasselbalch equation. At pH 5.5 the fractions are 15% and 4.8%; at pH 7 they are below 1%.0%25%50%75%100%Undissociated acid (HA)345678pH of the water phasepH 5 to 6 band, shown for referenceSorbic acid, pKa 4.76Sorbic acid: 50% undissociated at pH = pKa = 4.76Sorbic acid at pH 5.5: 15.4% undissociatedBenzoic acid, pKa 4.204Benzoic acid: 50% undissociated at pH = pKa = 4.204Benzoic acid at pH 5.5: 4.8% undissociated15.4%4.8%pH 5.5Sorbic acid, pKa 4.76Benzoic acid, pKa 4.20
Undissociated fraction = 1 / (1 + 10pH − pKa). pKa at 25 °C: sorbic acid 4.76, benzoic acid 4.204 (PubChem, Hazardous Substances Data Bank records, retrieved October 27, 2026). Mechanism of uptake: Krebs et al., Biochem J 1983;214:657–663.
Data table
Percent undissociated acid by pH
pHSorbic acidBenzoic acid
3.594.8%83.5%
4.085.2%61.5%
4.564.5%33.6%
5.036.5%13.8%
5.515.4%4.8%
6.05.4%1.6%
7.00.57%0.16%

Eklund T. J Gen Microbiol 1985;131:73–76. Nes IF, Eklund T. J Appl Bacteriol 1983;54:237–242. Gilbert P, Beveridge EG, Crone PB. Microbios 1977;19:125–141. Krebs HA et al. Biochem J 1983;214:657–663. Vaara M. Microbiol Rev 1992;56:395–411. Langsrud S et al. PLoS One 2016;11:e0165228. Leistner L. Int J Food Microbiol 2000;55:181–186.

EU limits

EU preservative limits

In the EU a substance used as a preservative must be listed in Annex V of Regulation 1223/2009 and used within its conditions (Article 14(1)(d)). Limits apply to the ready-for-use product, and for acids they are expressed as the acid. The table gives the entries as they stood in the point-in-time text of December 31, 2020; check CosIng or EUR-Lex for later amendments before relying on a value.

Selected Annex V entries (Regulation (EC) No 1223/2009)
EntrySubstanceMaximum in ready-for-use productOther conditions
1Benzoic acid and its sodium salt2.5% (acid) rinse-off, except oral; 1.7% oral; 0.5% leave-on–
3Salicylic acid and its salts0.5% (acid)Not in oral products (entry substituted by Reg. 2019/1966)
4Sorbic acid and its salts0.6% (acid)–
12Methyl- and ethylparaben and their salts0.4% (as acid) single ester; 0.8% (as acid) mixturesSubstituted by Reg. 1004/2014
12aButyl- and propylparaben and their salts0.14% (as acid) for their sum; 0.8% for mixtures with entry 12Not in leave-on products for the nappy area of children under 3
13Dehydroacetic acid and its sodium salt0.6% (as acid)Not in aerosol sprays
29Phenoxyethanol1.0%–
34Benzyl alcohol1.0%Other uses under Annex III
50Chlorphenesin0.3%–
57Methylisothiazolinone0.0015%Rinse-off products only

Regulation (EC) No 1223/2009, Annex V: as adopted (legislation.gov.uk, original EU text) and point-in-time version at December 31, 2020 (legislation.gov.uk), with amending Regulations (EU) No 344/2013, 1003/2014, 1004/2014, 2017/1224 and 2019/1966 as noted there. Entry 13 and 50 values from the adopted text. Article 14(1): consolidated text, EUR-Lex, version of September 1, 2025.

Preservative efficacy

Challenge testing

A challenge test inoculates the product with five reference organisms and counts survivors over 28 days. The EU safety report must include the results (Annex I, Part A, point 3). USP <51> is written for drug products; ISO 11930 for cosmetics, with two pass levels. Both standards are paywalled; the criteria below are taken from an FDA laboratory manual and a peer-reviewed reproduction.

Acceptance criteria: minimum log10 reduction from the initial count
StandardOrganismsDay 7Day 14Day 28
USP <51> Category 2 (topical, aqueous base)Bacteria–2.0NI vs day 14
USP <51> Category 2Yeasts and molds–NI vs initialNI vs initial
ISO 11930 criterion ABacteria33 and NI3 and NI
ISO 11930 criterion AC. albicans11 and NI1 and NI
ISO 11930 criterion AA. brasiliensis–01
ISO 11930 criterion BBacteria–33 and NI
ISO 11930 criterion BC. albicans–11 and NI
ISO 11930 criterion BA. brasiliensis–00 and NI

NI, no increase: for USP, not more than 0.5 log10 above the previous value (FDA PMM); ISO 11930 accepts a 0.5 log deviation. USP <51>: as reproduced in FDA ORA, Pharmaceutical Microbiology Manual, ORA.007 revision 02 (August 25, 2020), Chapter 1. ISO 11930:2019 Annex B: as reproduced in Martins E, Reis RL, Silva TH, Mar Drugs 2023;21(2):57, Table 2; Amendment 1:2022 not checked. ISO 11930:2019 is marked "to be revised" (ISO, stage 90.92).

ISO 11930 criterion A asks for a 3-log bacterial kill by day 7; USP Category 2 asks for 2 logs by day 14 and only no increase for fungiPlotted from the published criteria
Minimum log10 reductions from the inoculum required at days 7, 14 and 28 for bacteria, yeast and mold under USP <51> Category 2 (topical products) and ISO 11930 criteria A and B. ISO criterion A asks for a 3-log bacterial kill by day 7; USP Category 2 asks for 2 logs by day 14 and only no increase for fungi.Bacteria01234071428USP <51> Category 2, day 14: at least 2 log10 reductionUSP <51> Category 2, day 28: at least 2 log10 reduction (NI)ISO 11930 criterion A, day 7: at least 3 log10 reductionISO 11930 criterion A, day 14: at least 3 log10 reduction (NI)ISO 11930 criterion A, day 28: at least 3 log10 reduction (NI)ISO 11930 criterion B, day 14: at least 3 log10 reductionISO 11930 criterion B, day 28: at least 3 log10 reduction (NI)Yeast (C. albicans)01234071428USP <51> Category 2, day 14: at least 0 log10 reduction (NI*)USP <51> Category 2, day 28: at least 0 log10 reduction (NI*)ISO 11930 criterion A, day 7: at least 1 log10 reductionISO 11930 criterion A, day 14: at least 1 log10 reduction (NI)ISO 11930 criterion A, day 28: at least 1 log10 reduction (NI)ISO 11930 criterion B, day 14: at least 1 log10 reductionISO 11930 criterion B, day 28: at least 1 log10 reduction (NI)Mold (A. brasiliensis)01234071428USP <51> Category 2, day 14: at least 0 log10 reduction (NI*)USP <51> Category 2, day 28: at least 0 log10 reduction (NI*)ISO 11930 criterion A, day 14: at least 0 log10 reductionISO 11930 criterion A, day 28: at least 1 log10 reductionISO 11930 criterion B, day 14: at least 0 log10 reductionISO 11930 criterion B, day 28: at least 0 log10 reduction (NI)Minimum log10 reduction from the inoculum, by dayUSP <51> Category 2ISO 11930 criterion AISO 11930 criterion BDays after inoculation on the x-axis. NI: no increase over the previous count. NI*: no increase over the initial count.Minimum log10 reductions required at days 7, 14 and 28 for bacteria, yeast and mold under USP <51> Category 2 and ISO 11930 criteria A and B.Bacteria01234071428USP <51> Category 2, day 14: at least 2 log10 reductionUSP <51> Category 2, day 28: at least 2 log10 reduction (NI)ISO 11930 criterion A, day 7: at least 3 log10 reductionISO 11930 criterion A, day 14: at least 3 log10 reduction (NI)ISO 11930 criterion A, day 28: at least 3 log10 reduction (NI)ISO 11930 criterion B, day 14: at least 3 log10 reductionISO 11930 criterion B, day 28: at least 3 log10 reduction (NI)Yeast (C. albicans)01234071428USP <51> Category 2, day 14: at least 0 log10 reduction (NI*)USP <51> Category 2, day 28: at least 0 log10 reduction (NI*)ISO 11930 criterion A, day 7: at least 1 log10 reductionISO 11930 criterion A, day 14: at least 1 log10 reduction (NI)ISO 11930 criterion A, day 28: at least 1 log10 reduction (NI)ISO 11930 criterion B, day 14: at least 1 log10 reductionISO 11930 criterion B, day 28: at least 1 log10 reduction (NI)Mold (A. brasiliensis)01234071428USP <51> Category 2, day 14: at least 0 log10 reduction (NI*)USP <51> Category 2, day 28: at least 0 log10 reduction (NI*)ISO 11930 criterion A, day 14: at least 0 log10 reductionISO 11930 criterion A, day 28: at least 1 log10 reductionISO 11930 criterion B, day 14: at least 0 log10 reductionISO 11930 criterion B, day 28: at least 0 log10 reduction (NI)USP <51> Category 2ISO 11930 criterion AISO 11930 criterion B
Each marker is the minimum required at that sampling day; no requirement where no marker is shown. Sources as in the table above.
USP <51> method parameters, as reproduced by FDA
ParameterValue
Organisms (ATCC)C. albicans 10231, A. brasiliensis 16404, E. coli 8739, P. aeruginosa 9027, S. aureus 6538
Inoculum in product, Categories 1–31 × 10⁵ to 1 × 10⁶ CFU/mL; inoculum volume 0.5–1.0% of product volume
Incubation22.5 ± 2.5 °C
Sampling, Category 2Days 14 and 28

FDA ORA, Pharmaceutical Microbiology Manual, ORA.007 rev. 02 (August 25, 2020), Chapter 1, sections D–G. Regulation (EC) No 1223/2009, Annex I, Part A, point 3 (legislation.gov.uk, adopted text).

Shelf life

Stability testing conditions

No harmonized rule sets stability conditions for cosmetics. The EU requires the safety report to cover stability "under reasonably foreseeable storage conditions" (Annex I, Part A, point 2). ICH Q1A(R2), written for new drug substances and products, supplies the reference conditions and pull points used here. A consolidated ICH Q1 that will replace it was being revised after consultation, with Step 4 planned for November 2026.

ICH Q1A(R2) general-case storage conditions for drug products
StudyConditionMinimum data at submission
Long term25 ± 2 °C / 60 ± 5% RH, or 30 ± 2 °C / 65 ± 5% RH12 months
Intermediate30 ± 2 °C / 65 ± 5% RH6 months (only after significant change at the accelerated condition)
Accelerated40 ± 2 °C / 75 ± 5% RH6 months
Semi-permeable containers, long term25 ± 2 °C / 40 ± 5% RH, or 30 ± 2 °C / 35 ± 5% RH; accelerated 40 °C / not more than 25% RH12 months; 6 months

ICH Q1A(R2), Step 4 version dated February 6, 2003, sections 2.2.6–2.2.7. ICH Q1 EWG work plan, February 11, 2026 (Step 4 expected November 2026). EMA page for the Step 2b draft ICH Q1 (EMA/CHMP/ICH/130561/2025). Regulation (EC) No 1223/2009, Annex I, Part A, point 2.

Three ICH conditions with their pull points over 36 months; freeze–thaw cycling has no ICH conditionICH Q1A(R2) conditions; schematic cabinets
Four schematic stability cabinets: long term at 25 °C and 60% relative humidity, intermediate at 30 °C and 65%, accelerated at 40 °C and 75%, and a freeze–thaw cabinet with no prescribed condition. Below, a 36-month timeline shows ICH Q1A(R2) pull points: long term every 3 months in year one, every 6 months in year two and annually after that; accelerated at 0, 3 and 6 months; intermediate at 0, 6, 9 and 12 months, run only when the accelerated condition shows a significant change.
ICH Q1A(R2), Stability Testing of New Drug Substances and Products, Step 4 version of February 6, 2003, sections 2.2.6–2.2.7. Cabinets schematic, not to scale. Illustration by EUTECNIQ. Full-size SVG
Extrapolation

What accelerated data can predict

Heat speeds a chemical reaction by a factor set by its activation energy (Arrhenius), often summarized as Q10, the rate ratio for a 10 °C rise. That arithmetic holds only while one mechanism governs; ICH Q1A says extrapolation "assumes that the same degradation relationship will continue to apply" and notes that creams may melt at accelerated conditions. Melting, phase inversion and emulsifier crystallization are threshold events, not rates, so no Q10 describes them.

Six months at 40 °C stands in for 17, 31 or 48 months at 25 °C only if Q10 is truly 2, 3 or 4Computed; Q10 values are assumptions
Acceleration factor relative to 25 °C, Q10 to the power (T − 25)/10, for assumed Q10 values of 2, 3 and 4. At 40 °C the factors are 2.8, 5.2 and 8.0, so six months at 40 °C stands in for 17, 31 or 48 months at 25 °C only if one degradation mechanism with that temperature sensitivity governs shelf life.125102040Rate relative to 25 °C (log scale)25 °C30 °C35 °C40 °C45 °C50 °CStorage temperature40 °C / 75% RH (ICHaccelerated)Q10 = 2Q10 = 2: factor 2.83 at 40 °C; 6 months at 40 °C ≈ 17 months at 25 °CQ10 = 2Ea ≈ 53 kJ/molQ10 = 3Q10 = 3: factor 5.20 at 40 °C; 6 months at 40 °C ≈ 31 months at 25 °CQ10 = 3Ea ≈ 84 kJ/molQ10 = 4Q10 = 4: factor 8.00 at 40 °C; 6 months at 40 °C ≈ 48 months at 25 °CQ10 = 4Ea ≈ 106 kJ/molAcceleration factor relative to 25 °C, Q10 to the power (T − 25)/10, for assumed Q10 values of 2, 3 and 4. At 40 °C the factors are 2.8, 5.2 and 8.0, so six months at 40 °C stands in for 17, 31 or 48 months at 25 °C only if one degradation mechanism with that temperature sensitivity governs shelf life.125102040Rate relative to 25 °C (log scale)25 °C30 °C35 °C40 °C45 °C50 °CStorage temperature40 °C /75% RH(ICHaccelerated)Q10 = 2Q10 = 2: factor 2.83 at 40 °C; 6 months at 40 °C ≈ 17 months at 25 °CQ10 = 3Q10 = 3: factor 5.20 at 40 °C; 6 months at 40 °C ≈ 31 months at 25 °CQ10 = 4Q10 = 4: factor 8.00 at 40 °C; 6 months at 40 °C ≈ 48 months at 25 °CQ10 = 2 (Ea ≈ 53 kJ/mol)Q10 = 3 (Ea ≈ 84 kJ/mol)Q10 = 4 (Ea ≈ 106 kJ/mol)
Acceleration factor = Q10(T − 25)/10; at 40 °C, 2.83, 5.20 and 8.00. Equivalent activation energy over 25–35 °C, Ea = R·ln Q10 / (1/298.15 K − 1/308.15 K): 52.9, 83.9 and 105.9 kJ/mol. A constant Q10 and a constant Ea are not the same assumption over wide ranges.
What a stability program checks beyond the chemical assay
Stress or checkWhat it revealsSource
"Significant change" criteriaFor drug products: 5% assay change, a degradant over its limit, failure of appearance or physical attributes (color, phase separation), pHICH Q1A(R2) 2.2.7.1
Freeze–thaw cyclingIn W/O emulsions, stability depends on whether the emulsifier crystallizes at the interface and which phase solidifies first; no ICH condition exists, so cycles are set by the developerGhosh and Rousseau, J Colloid Interface Sci 2009; Degner et al., Compr Rev Food Sci Food Saf 2014
Water loss through the packAqueous products in semi-permeable containers are tested for water loss at low humidityICH Q1A(R2) 2.2.7.3
Packaging compatibilityThe EU safety report must cover the relevant characteristics of the packaging material, in particular purity and stabilityReg. 1223/2009, Annex I, Part A, point 4

ICH Q1A(R2) (2003), sections 2.2.7.1, 2.2.7.3 and 2.2.9; glossary entry "mean kinetic temperature" (Arrhenius). Waterman KC et al. Pharm Res 2007;24:780–790 (humidity-corrected Arrhenius protocol for solids). Ghosh S, Rousseau D. J Colloid Interface Sci 2009;339:91–102. Degner BM et al. Compr Rev Food Sci Food Saf 2014;13:98–113.

EU law

Regulation 1223/2009 basics

Five annexes control what may go into an EU cosmetic, and Article 19 controls what the label says about shelf life. A product with a minimum durability of 30 months or less shows a date; above 30 months it shows the period after opening: the Annex VII point 2 symbol followed by months or years. US cosmetic duties under MoCRA are covered on Cosmetics and MoCRA.

Annexes and labeling rules of Regulation (EC) No 1223/2009 relevant to a botanical formula
ProvisionRule
Annex IISubstances prohibited in cosmetic products
Annex IIISubstances allowed only under its restrictions
Annex IVColorants allowed, and their conditions
Annex VPreservatives allowed, and their conditions
Annex VIUV filters allowed, and their conditions
Article 19(1)(c)Date of minimum durability, introduced by "best used before the end of" or the Annex VII point 3 symbol; not mandatory above 30 months, where the period after opening is shown with the Annex VII point 2 symbol
Reg. (EU) 2023/1545Fragrance allergens labeled individually above 0.001% in leave-on and 0.01% in rinse-off products; 24 allergens were already listed, the SCCS identified 56 more, and the annex adds entries 327–371, including Lavandula and Citrus oils
2023/1545 transitionNon-compliant products may be placed on the market until July 31, 2026 and made available until July 31, 2028

Regulation (EC) No 1223/2009, Articles 14(1) and 19(1)(c) (EUR-Lex consolidated version of September 1, 2025; legislation.gov.uk adopted text) and Annex VII (symbols: enclosed information, period after opening, date of minimum durability). Commission Regulation (EU) 2023/1545 of July 26, 2023 (OJ July 27, 2023), recitals 5–7 and 11 and Annex footnotes.

Proposed

Where EUTECNIQ would work

Proposed EUTECNIQ is designed to characterize botanical actives and supply formulation, stability and compatibility data that a brand's safety assessor can use. Challenge tests would be run by qualified partner laboratories. None of this work has started.

Related: Cosmetics and personal care · Cosmetics and MoCRA · Emulsions and colloids · Scale-up and tech transfer

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.